Tramiprosate, an oral amyloid anti-aggregation agent, shows robust cognitive efficacy in APOE4/4 homozygous ad patients: efficacy and safety analyses from two Phase 3 trials
Abushakra, Susan, Vellas, Bruno, Cummings, Jeffrey, Hey, John, Tolar, Martin, Power, AidanVolume:
39
Language:
english
Journal:
Neurobiology of Aging
DOI:
10.1016/j.neurobiolaging.2016.01.099
Date:
March, 2016
File:
PDF, 51 KB
english, 2016